About Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis
During the past decade, Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus
2018-02-06
2019-12-26
Completed
72
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
2018-08-15
2019-10-04
Completed
4,819
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis
According to Clinical.Site data, the most researched conditions in "Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis" are
"Pulmonary Disease, Chronic Obstructive" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis" in a lesser frequency.
Clinical Trials Intervention Types at Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis
Most popular intervention types in "Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "JNJ-53718678 500 mg" (1 trials), "JNJ-53718678 80 mg" (1 trials), "Placebo" (1 trials) and "Spiolto® Respimat®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis
The vast majority of trials in "Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis" are
2 trials for "All" genders.
Clinical Trials Status at Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis
Currently, there are NaN active trials in "Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Indywidualna Specjalistyczna Praktyka Lekarska Lek. Krzysztof Lis, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".